FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1948341469> ?p ?o ?g. }

• W1948341469 endingPage "7" @default.
• W1948341469 startingPage "500" @default.
• W1948341469 abstract "Pertechnetate (as (99m)TcO(4)(-)), (123)I(-), and (131)I(-) have a long and successful history of use in the diagnosis and therapy of thyroid cancer, with uptake into thyroid tissue mediated by the sodium-iodide symporter (NIS). NIS has also emerged as a potential target for radiotherapy of nonthyroid malignancies that express the endogenous or transfected symporter. Perrhenates (as (188)ReO(4)(-) and (186)ReO(4)(-)) are promising therapeutic substrates of NIS, although less is known about their behavior in vivo. In this study, we endeavored to characterize the biologic behavior of perrhenate, especially in relation to iodide and pertechnetate, to better explore its possible therapeutic role.We describe the simultaneous biodistribution and uptake in vivo of iodide, pertechnetate, and perrhenate in groups of healthy CD1 mice, either with or without coadministration of perchlorate (ClO(4)(-)), a potent NIS inhibitor. Animals administered single radiopharmaceuticals were imaged as a means of illustrating these findings. Kinetic properties of perrhenate were compared with those of iodide in a stably transfected NIS-bearing Madin-Darby canine kidney (MDCK) cell line.Biodistributions of iodide, pertechnetate, and perrhenate in live mice were remarkably similar. Activity in salivary gland and stomach was severalfold greater than in blood, remained elevated over the initial 2 h, and subsequently washed out. A similar pattern characterized pertechnetate and perrhenate uptake by the thyroid, in which the 2-h concentration was slightly more elevated than at the 20-min time point. However, uptake subsequently decreased by 19 h. In contrast, iodide continued to increase through the 19-h time point, presumably as a result of organification. The addition of perchlorate sharply decreased uptake of all 3 radiopharmaceuticals by the stomach, salivary glands, and thyroid and resulted in their rapid clearance, paralleling blood-pool clearance. In tissues that do not express NIS (liver, muscle, spleen), uptake of all 3 radiopharmaceuticals was low and rapidly decreased over time, paralleling blood-pool clearance. Similar findings were seen in kidney, where only minimal amounts of NIS are expressed in tubular cells. In stably transfected MDCK cells, steady-state accumulation of iodide was approximately 4-fold higher than that of perrhenate at 30 min. No active transport was demonstrated in nontransfected MDCK cell lines or after perchlorate administration. Uptake values measured at different concentrations of substrate demonstrated saturation kinetics. Apparent maximal velocity values for perrhenate and iodide were 25.6 +/- 1.4 and 106 +/- 3.2 pmol/ micro g, respectively, and corresponding affinity constant values were 4.06 +/- 0.87 and 24.6 +/- 1.81 micro mol/L.Perrhenate is avidly taken up by NIS in a manner similar to iodide and pertechnetate in vivo, with the exception of organification of iodide by the thyroid. By more fully appreciating the behavior of perrhenate, especially in relation to iodide and pertechnetate, we can better realize its potential role in the diagnosis and therapy of NIS-bearing tissues." @default.
• W1948341469 created "2016-06-24" @default.
• W1948341469 creator A5014358490 @default.
• W1948341469 creator A5034610205 @default.
• W1948341469 creator A5036750375 @default.
• W1948341469 creator A5049126875 @default.
• W1948341469 creator A5064842058 @default.
• W1948341469 creator A5078704171 @default.
• W1948341469 date "2004-03-01" @default.
• W1948341469 modified "2023-09-30" @default.
• W1948341469 title "Kinetics of perrhenate uptake and comparative biodistribution of perrhenate, pertechnetate, and iodide by NaI symporter-expressing tissues in vivo." @default.
• W1948341469 cites W1491403843 @default.
• W1948341469 cites W1579892113 @default.
• W1948341469 cites W1944345666 @default.
• W1948341469 cites W1967981106 @default.
• W1948341469 cites W1986199849 @default.
• W1948341469 cites W1986513627 @default.
• W1948341469 cites W2002338610 @default.
• W1948341469 cites W2009251525 @default.
• W1948341469 cites W2023180335 @default.
• W1948341469 cites W2026316938 @default.
• W1948341469 cites W2034083247 @default.
• W1948341469 cites W2046061197 @default.
• W1948341469 cites W2049344067 @default.
• W1948341469 cites W2050290751 @default.
• W1948341469 cites W2054970048 @default.
• W1948341469 cites W2056752715 @default.
• W1948341469 cites W2064022012 @default.
• W1948341469 cites W2064806925 @default.
• W1948341469 cites W2065003195 @default.
• W1948341469 cites W2065453464 @default.
• W1948341469 cites W2075708289 @default.
• W1948341469 cites W2079883897 @default.
• W1948341469 cites W2081852249 @default.
• W1948341469 cites W2082832566 @default.
• W1948341469 cites W2091590087 @default.
• W1948341469 cites W2101452381 @default.
• W1948341469 cites W2118980760 @default.
• W1948341469 cites W2120223211 @default.
• W1948341469 cites W2138994122 @default.
• W1948341469 cites W2145621549 @default.
• W1948341469 cites W2151428570 @default.
• W1948341469 cites W2153876645 @default.
• W1948341469 cites W2154909949 @default.
• W1948341469 cites W2161469472 @default.
• W1948341469 cites W2185455477 @default.
• W1948341469 cites W2215511138 @default.
• W1948341469 cites W2331426277 @default.
• W1948341469 cites W2417921638 @default.
• W1948341469 cites W2432517183 @default.
• W1948341469 cites W3004157836 @default.
• W1948341469 cites W3097169496 @default.
• W1948341469 cites W963710407 @default.
• W1948341469 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15001694" @default.
• W1948341469 hasPublicationYear "2004" @default.
• W1948341469 type Work @default.
• W1948341469 sameAs 1948341469 @default.
• W1948341469 citedByCount "41" @default.
• W1948341469 countsByYear W19483414692013 @default.
• W1948341469 countsByYear W19483414692014 @default.
• W1948341469 countsByYear W19483414692015 @default.
• W1948341469 countsByYear W19483414692017 @default.
• W1948341469 countsByYear W19483414692018 @default.
• W1948341469 countsByYear W19483414692019 @default.
• W1948341469 countsByYear W19483414692020 @default.
• W1948341469 countsByYear W19483414692021 @default.
• W1948341469 countsByYear W19483414692022 @default.
• W1948341469 countsByYear W19483414692023 @default.
• W1948341469 crossrefType "journal-article" @default.
• W1948341469 hasAuthorship W1948341469A5014358490 @default.
• W1948341469 hasAuthorship W1948341469A5034610205 @default.
• W1948341469 hasAuthorship W1948341469A5036750375 @default.
• W1948341469 hasAuthorship W1948341469A5049126875 @default.
• W1948341469 hasAuthorship W1948341469A5064842058 @default.
• W1948341469 hasAuthorship W1948341469A5078704171 @default.
• W1948341469 hasConcept C104317684 @default.
• W1948341469 hasConcept C120405084 @default.
• W1948341469 hasConcept C126322002 @default.
• W1948341469 hasConcept C13965031 @default.
• W1948341469 hasConcept C149011108 @default.
• W1948341469 hasConcept C150903083 @default.
• W1948341469 hasConcept C177322064 @default.
• W1948341469 hasConcept C179104552 @default.
• W1948341469 hasConcept C185592680 @default.
• W1948341469 hasConcept C202751555 @default.
• W1948341469 hasConcept C207001950 @default.
• W1948341469 hasConcept C2776230795 @default.
• W1948341469 hasConcept C2777807558 @default.
• W1948341469 hasConcept C2778136224 @default.
• W1948341469 hasConcept C2778870691 @default.
• W1948341469 hasConcept C2780616701 @default.
• W1948341469 hasConcept C505216180 @default.
• W1948341469 hasConcept C522557706 @default.
• W1948341469 hasConcept C526584372 @default.
• W1948341469 hasConcept C55493867 @default.
• W1948341469 hasConcept C71924100 @default.
• W1948341469 hasConcept C86803240 @default.
• W1948341469 hasConceptScore W1948341469C104317684 @default.

• next